283 related articles for article (PubMed ID: 31182451)
1. Increasing age- and gender-specific burden and complexity of multimorbidity in Taiwan, 2003-2013: a cross-sectional study based on nationwide claims data.
Hu RH; Hsiao FY; Chen LJ; Huang PT; Hsu WW
BMJ Open; 2019 Jun; 9(6):e028333. PubMed ID: 31182451
[TBL] [Abstract][Full Text] [Related]
2. Patterns and temporal trends of comorbidity among adult patients with incident cardiovascular disease in the UK between 2000 and 2014: A population-based cohort study.
Tran J; Norton R; Conrad N; Rahimian F; Canoy D; Nazarzadeh M; Rahimi K
PLoS Med; 2018 Mar; 15(3):e1002513. PubMed ID: 29509757
[TBL] [Abstract][Full Text] [Related]
3. Widening inequalities in multimorbidity? Time trends among the working population between 2005 and 2015 based on German health insurance data.
Tetzlaff J; Epping J; Sperlich S; Eberhard S; Stahmeyer JT; Geyer S
Int J Equity Health; 2018 Jul; 17(1):103. PubMed ID: 30012163
[TBL] [Abstract][Full Text] [Related]
4. Socioeconomic inequalities in the prevalence of complex multimorbidity in a Norwegian population: findings from the cross-sectional HUNT Study.
Vinjerui KH; Bjerkeset O; Bjorngaard JH; Krokstad S; Douglas KA; Sund ER
BMJ Open; 2020 Jun; 10(6):e036851. PubMed ID: 32546494
[TBL] [Abstract][Full Text] [Related]
5. Burden of multimorbidity in relation to age, gender and immigrant status: a cross-sectional study based on administrative data.
Lenzi J; Avaldi VM; Rucci P; Pieri G; Fantini MP
BMJ Open; 2016 Dec; 6(12):e012812. PubMed ID: 28003289
[TBL] [Abstract][Full Text] [Related]
6. Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000-2009 Nationwide Health Insurance database.
Jiang YD; Chang CH; Tai TY; Chen JF; Chuang LM
J Formos Med Assoc; 2012 Nov; 111(11):599-604. PubMed ID: 23217595
[TBL] [Abstract][Full Text] [Related]
7. The prevalence and determinants of multimorbidity in hospitalized patients with heart failure.
Siga O; Wizner B; Piotrowicz K; Fedyk-Łukasik M; Grodzicki T
Folia Med Cracov; 2017; 57(2):73-86. PubMed ID: 29121039
[TBL] [Abstract][Full Text] [Related]
8. Multimorbidity prevalence and pattern in Indonesian adults: an exploratory study using national survey data.
Hussain MA; Huxley RR; Al Mamun A
BMJ Open; 2015 Dec; 5(12):e009810. PubMed ID: 26656028
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of upper urinary tract stone disease in a Taiwanese population: a nationwide, population based study.
Huang WY; Chen YF; Carter S; Chang HC; Lan CF; Huang KH
J Urol; 2013 Jun; 189(6):2158-63. PubMed ID: 23313204
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of multimorbidity in Iran: An investigation of a large pharmacy claims database.
Ebrahimoghli R; Janati A; Sadeghi-Bazargani H; Hamishehkar H; Ghaffari S; Sanaat Z; Farahbakhsh M; Farhoudi M; Khalili-Azimi A
Pharmacoepidemiol Drug Saf; 2020 Jan; 29(1):39-47. PubMed ID: 31730260
[TBL] [Abstract][Full Text] [Related]
11. Trends in the utilization of acupuncture among children in Taiwan from 2002 to 2011: a nationwide population-based study.
Wang C; Lee YC; Wu MY; Lin CL; Sun MF; Lin JG; Yen HR
BMC Complement Altern Med; 2019 Nov; 19(1):328. PubMed ID: 31752791
[TBL] [Abstract][Full Text] [Related]
12. Burden of multimorbidity, socioeconomic status and use of health services across stages of life in urban areas: a cross-sectional study.
Violán C; Foguet-Boreu Q; Roso-Llorach A; Rodriguez-Blanco T; Pons-Vigués M; Pujol-Ribera E; Muñoz-Pérez MÁ; Valderas JM
BMC Public Health; 2014 May; 14():530. PubMed ID: 24885174
[TBL] [Abstract][Full Text] [Related]
13. Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015.
van den Akker M; Vaes B; Goderis G; Van Pottelbergh G; De Burghgraeve T; Henrard S
PLoS One; 2019; 14(2):e0212046. PubMed ID: 30753214
[TBL] [Abstract][Full Text] [Related]
14. The disease burden of multimorbidity and its interaction with educational level.
Chen YH; Karimi M; Rutten-van Mölken MPMH
PLoS One; 2020; 15(12):e0243275. PubMed ID: 33270760
[TBL] [Abstract][Full Text] [Related]
15. Estimating multimorbidity prevalence with the Canadian Chronic Disease Surveillance System.
Feely A; Lix LM; Reimer K
Health Promot Chronic Dis Prev Can; 2017 Jul; 37(7):215-222. PubMed ID: 28703703
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of multimorbidity among Bangladeshi adult population: a nationwide cross-sectional study.
Khan N; Rahman M; Mitra D; Afsana K
BMJ Open; 2019 Nov; 9(11):e030886. PubMed ID: 31784434
[TBL] [Abstract][Full Text] [Related]
17. Rising burden of multimorbidity and related socio-demographic factors: a repeated cross-sectional study of Ontarians.
Kone AP; Mondor L; Maxwell C; Kabir US; Rosella LC; Wodchis WP
Can J Public Health; 2021 Aug; 112(4):737-747. PubMed ID: 33847995
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of multimorbidity in New Zealand: a cross-sectional study using national-level hospital and pharmaceutical data.
Stanley J; Semper K; Millar E; Sarfati D
BMJ Open; 2018 May; 8(5):e021689. PubMed ID: 29794103
[TBL] [Abstract][Full Text] [Related]
19. Disease and economic burden for rare diseases in Taiwan: A longitudinal study using Taiwan's National Health Insurance Research Database.
Hsu JC; Wu HC; Feng WC; Chou CH; Lai EC; Lu CY
PLoS One; 2018; 13(9):e0204206. PubMed ID: 30240449
[TBL] [Abstract][Full Text] [Related]
20. Multimorbidity among middle-aged and older persons in urban China: Prevalence, characteristics and health service utilization.
Chen H; Cheng M; Zhuang Y; Broad JB
Geriatr Gerontol Int; 2018 Oct; 18(10):1447-1452. PubMed ID: 30178629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
